180 Life Sciences plans $2.9m stock offering during iGaming pivot
180 Life Sciences plans to raise about $2.9m through a direct stock offering as it shifts towards online gaming and gambling, according to a 30 December filing with the US Securities and Exchange Commission. The proposed sale covers 1.2 million common shares at $2.41 each, alongside warrants for another 1.2 million shares; the company expects the proceeds to support its market entry efforts.
The proposed raise would finance 180 Life Sciences’ transition into the iGaming sector.